---
title: "PSP CurePSP-Tau WGS"
id: "2418"
type: "sample_set"
slug: "snd10016"
published_at: "2021-02-24T01:26:59+00:00"
modified_at: "2023-12-14T22:29:52+00:00"
url: "https://dss.niagads.org/sample-sets/snd10016/"
markdown_url: "https://dss.niagads.org/sample-sets/snd10016.md"
excerpt: "PSP CurePSP and Tau Consortium samples were whole-genome sequenced at Macrogen on the HiSeqX machine. FASTQ files were sent to GCAD for processing on the VCPA1.1 pipeline. 886 samples passed sequencing metrics and quality control."
---

## Description

PSP CurePSP and Tau Consortium samples were whole-genome sequenced at Macrogen on the HiSeqX machine. FASTQ files were sent to GCAD for processing on the VCPA1.1 pipeline. 886 samples passed sequencing metrics and quality control.

## Cohorts

- [Progressive Supranuclear Palsy (PSP)](https://dss.niagads.org/cohorts/progressive-supranuclear-palsy-psp/)

## Sex

### Total number of samples: 886

Female39744.8 %

Male48955.2 %

## Race

### Total number of samples: 886

| White | 869 |
| --- | --- |
| NA | 17 |

## Diagnosis

### Total number of samples: 886

| PSP |  |  |
| --- | --- | --- |
| Case | 886 | 100.0% |